BOSTON and CAMBRIDGE, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics and ConcertAI announced the first phase of their Translational Oncology partnership, aligned around Dewpoint’s ...
The editor’s pick for this issue is a review article discussing the promise of hyperpolarised xenon MRI, a non-invasive ...
Executives at a local company believe they have a quicker and less expensive path to get their new drug approved.
Discover the critical shortage of physician-scientists, funding, and mentorship in pediatric research and its potential impact on patient care.
The clinical trial is divided into two phases. During the first phase, up to 60 subjects, ages 7 to 17 with ADHD will be enrolled at four sites in Denmark to receive active or sham eTNS treatment for ...
Over the past two decades, awareness has grown about the wide-ranging applications of genomic technologies in human health and beyond.1 This awareness was further heightened during the coronavirus ...
Josh Jennings, an analyst from TD Cowen, maintained the Buy rating on TransMedics Group (TMDX – Research Report). The associated price target ...
The Amyloidosis market was $3.6 billion in 2017, and is expected to reach $6 billion in 2025, according to Grand View Research.
Traumatic brain injury (TBI) is a leading cause of death and disability among young people in the United States and is the most devastating survivable injury in modern warfare, according to the ...
Technologies developed by UC San Diego and Scripps Research teams will map the human eye-brain connectome, extend the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback